FDA Approval to Use Stem Cell Therapy for COVID-19 Patients Under Compassionate Use Program

In Features 21 by Mary Kurek1 Comment

Deven Patel is President and CEO of Giostar (Global Institute of Stem Cell Therapy and Research).  Deven is no stranger to Frontrunners Innovate, regularly bringing us updates on stem cell therapies and trials as they move closer to their goal of the world’s largest clinical trial.  During the pandemic, however, Giostar turned its attention toward solutions that could help those suffering.  Their hard work is paying off and with a nod from the FDA, they are onward to trials that could make a difference to moving the needle on numbers of recoveries.  Check out the video below and this link to Channel 10/ABC News clip.   We’re sharing Giostar’s announcement article also.  If you have a contact for Giostar that could be a good trial facility, you can find Deven through his Linkedin profileGiostar site.

 

Giostar’s announcement below:

Comments

  1. Pingback: Update May 2020: Innovator Survey-Hackathon-Partner Request - The Frontrunners League

Leave a Reply